CorMedix Inc. (CRMD) Share Price

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 10.34 High: 10.68
52 Week Range
Low: 3.03 High: 13.85
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market capMarket cap information

    $610 Mln

  • P/E RatioP/E Ratio information

    --

  • P/B RatioP/B Ratio information

    10.39

  • Industry P/EIndustry P/E information

    39.67

  • Debt to EquityDebt to Equity information

    0

  • ROEROE information

    -0.65 %

  • ROCEROCE information

    --

  • Div. YieldDiv. Yield information

    0 %

  • Book ValueBook Value information

    --

  • EPSEPS information

    -0.83

10 Years Aggregate

CFO

$-214.34 Mln

EBITDA

$-266.00 Mln

Net Profit

$-265.84 Mln

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CorMedix (CRMD)
29.38 -5.76 -7.67 240.26 38.20 11.14 -4.35
BSE Sensex
-2.95 -0.51 -2.25 6.13 9.30 12.87 10.07
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 14-Feb-2025  |  #As on 26-Oct-2023
2024
2023
2022
2021
2020
2019
2018
CorMedix (CRMD)
114.08 -10.90 -7.25 -38.76 2.06 12.87 155.65
S&P Small-Cap 600
7.01 13.89 -17.42 25.27 9.57 20.86 -9.70
BSE Sensex
8.10 18.74 4.44 21.99 15.75 14.38 5.87

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios view all

loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...
P/E Ratio

--

--Min --Median --Max

loading...
P/B Ratio

--

--Min --Median --Max

loading...
Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer view all

Company
Price ($) Market Cap ($ Mln) P/E Ratio ROE
64.85 12,551.80 39.67 6.15
63.50 11,522.38 -- -11.55
72.72 7,349.97 55.67 23.81
10.80 12,664.03 -- -4.44

Shareholding Pattern Detailed Holdings

loading...
BLAHBLAH

About The Company

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an...  antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922  Read more

  • CEO & Director

    Mr. Joseph Todisco MBA

  • CEO & Director

    Mr. Joseph Todisco MBA

  • Headquarters

    Berkeley Heights, NJ

  • Website

    https://www.cormedix.com

Edit peer-selector-edit
loading...
loading...

FAQs for CorMedix Inc. (CRMD)

The total asset value of CorMedix Inc (CRMD) stood at $ 96 Mln as on 30-Sep-24

The share price of CorMedix Inc (CRMD) is $10.48 (NASDAQ) as of 14-Feb-2025 16:05 EST. CorMedix Inc (CRMD) has given a return of 38.2% in the last 3 years.

CorMedix Inc (CRMD) has a market capitalisation of $ 610 Mln as on 13-Feb-2025. As per Value Research classification, it is a Small Cap company.

The P/B ratio of CorMedix Inc (CRMD) is 10.39 times as on 13-Feb-2025, a 106% premium to its peers’ median range of 5.04 times.

Since, TTM earnings of CorMedix Inc (CRMD) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the CorMedix Inc (CRMD) and enter the required number of quantities and click on buy to purchase the shares of CorMedix Inc (CRMD).

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922

The CEO & director of Mr. Joseph Todisco MBA. is CorMedix Inc (CRMD), and CFO & Sr. VP is Mr. Joseph Todisco MBA.

There is no promoter pledging in CorMedix Inc (CRMD).

CorMedix Inc. (CRMD) Ratios
Return on equity(%)
-79.07
Operating margin(%)
-378.13
Net Margin(%)
-367.24
Dividend yield(%)
--

No, TTM profit after tax of CorMedix Inc (CRMD) was $0 Mln.